keeping an eye on it seems to be little buying periods then pushed down or allowed to weaken.. last trade is 500 shares at 26.5 who sells 130$ worth of shares :/
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
